Back Login to subscribe 🔔 Set Alert

A Agilent Technologies Inc.

15 min delay
Today's News Sentiment
Loading...
Upcoming Earnings
Loading...
A Fundamental Data
Loading...
A Options Chain
Put/Call Ratio
—
—
Expected Move
—
—
Max Pain
—
—
ATM Call Break-even
—
—
ATM Put Break-even
—
—
Loading options…
CALLS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
PUTS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
A Insider Transactions
Loading insider data…
A News
Date Headline Sentiment
12 Health Care Stocks Moving In Thursday's Pre-Market Session
96.77%
Micron To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Thursday
77.37%
Agilent Technologies shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 adjusted EPS guidance above estimates. Also, the company narrowed its FY26 sales guidance above estimates.
95.33%
B of A Securities Upgrades Agilent Technologies to Buy, Lowers Price Target to $145
62.05%
Agilent Technologies Says Middle East-Driven Inflation May Weigh On Capital Spending, But Sees Strong Recovery Accelerating
89.93%
12 Health Care Stocks Moving In Wednesday's After-Market Session
96.88%
Agilent Technologies Lowers Food Outlook To Low Single-Digit Decline On Funding Delays In China, India, Inflation Headwinds Related To The Middle East Conflict; Says Cost Pressures From Middle East Conflict, Chip Demand To Be Offset By Ignite Efficiencies In H2
89.93%
Agilent Technologies Says In Conference Call That AI A Key FY26 Enterprise Focus Area; GLP-1 Driving ~20% Of YTD Growth; Muted But Stabilizing Research Funding Environment Weighs On Instrument Spend; Expects High Single-Digit Growth In Pharma, Low Single-Digit Decline In Academic And Government In Q3
92.99%
Agilent Technologies shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 adjusted EPS guidance above estimates. Also, the company narrowed its FY26 sales guidance above estimates.
95.33%
Agilent Technologies Raises FY2026 Adj EPS Guidance from $5.90-$6.04 to $6.00-$6.10 vs $5.98 Est; Narrows FY2026 Sales Guidance from $7.300B-$7.500B to $7.390B-$7.490B vs $7.384B Est
89.93%